Director Larry Padfield of Innospec INC (NASDAQ:IOSP) executed multiple equity transactions in February 2026, according to regulatory filings. On February 20, 2026, Padfield sold 1,030 shares of Innospec common stock at a per-share price of $81.8409, producing gross proceeds of $84,296.
On the same day, Padfield also exercised stock options to buy 1,030 shares of Innospec common stock at an exercise price of $44.18 per share, for a total exercise cost of $45,505. Those exercised options and the contemporaneous sale are recorded in the filings as separate actions completed on February 20, 2026.
Several days later, on February 23, 2026, Padfield was recorded as acquiring 1,539 shares of Innospec common stock that carried a reported value of $0 in the filing. Those shares are restricted stock units granted as part of Padfield's compensation for service as a non-employee director and are scheduled to vest in full on February 23, 2029.
The transactions occurred while Innospec, a specialty chemicals company with a market capitalization of $1.96 billion, was trading at $79.30 per share. The filing commentary notes that this trading price is below the company's InvestingPro Fair Value estimate, suggesting the stock may be undervalued according to that metric.
Additional company context included in the filings highlights a long-running record of dividend increases. According to InvestingPro Tips cited in the disclosure, Innospec has raised its dividend for 12 consecutive years, a datapoint that underscores a pattern of shareholder distributions.
The set of actions by Padfield - sale, option exercise, and restricted stock unit vesting - are documented in the corporate filings and reflect routine director-level equity activity. The filings specify dates, quantities, prices and the vesting schedule for the restricted awards without providing further commentary on future trading plans or corporate strategy.
Clear summary
Director Larry Padfield sold 1,030 Innospec shares on February 20, 2026 for $81.8409 each, exercised options for 1,030 shares at $44.18 per share on the same date, and on February 23, 2026 had 1,539 restricted stock units recorded as acquired with a zero reported value that vest in full on February 23, 2029. At the time, Innospec had a market cap of $1.96 billion and was trading at $79.30, below its InvestingPro Fair Value estimate. The company has also increased its dividend for 12 consecutive years according to InvestingPro Tips.